Seker Sebahat, Abasiyanik M Fatih, Salih Barik A
Department of Biology/Microbiology, Faculty of Science and Literature, Fatih University, B.cekmece, Istanbul, Turkey.
Saudi Med J. 2004 May;25(5):575-9.
Rubella immunization rates are not optimal and infections during pregnancy still occur since many countries incorporate no rubella vaccine in their national immunization program. The evaluation of immunity to rubella virus relies on the presence of specific antibodies. This study was undertaken to determine in a cross-sectional survey whether rubella virus circulation in the Istanbul city, induces detectable immunoglobulin G (IgG) antibodies with a protective level, in a random group of pregnant and non-pregnant women.
One hundred and sixty women of 20-41-years of age (average 24-years) were grouped as follows: 1. Forty-eight married women. Among these were 41 pregnant women (33 delivered normally, 8 aborted). 2. One hundred and twelve single women. Samples were collected during the periods from October 2000 through to March 2001 and from November 2001 through to May 2002. Rubella specific IgG antibodies were detected (by the ELISA test) in all women tested.
Quantitative analysis of the IgG levels showed noticeable variability that ranged between 24-143 IU/ml (average 94). One hundred and forty-five (91%) out of 160 women had rubella IgG levels of above 50 IU/ml with a range of 54-143 IU/ml (average 92) while 15 (9%) had a level between 24-46 IU/ml (average 38). Rubella IgG-avidity test revealed that 116 (73%) of women had high IgG avidity, 22 (14%) had intermediate avidity and 20 (13%) showed low avidity. Two women who were IgM positive, each had either high or intermediate IgG avidity.
All women tested were seropositive for rubella specific IgG antibodies suggestive of natural virus circulation within the community. Although the majority appeared to possess protective level of such antibodies, screening for protective immunity appears always to be a necessity for future protection against reinfection.
风疹免疫接种率并不理想,且由于许多国家在其国家免疫规划中未纳入风疹疫苗,孕期感染仍时有发生。对风疹病毒免疫力的评估依赖于特定抗体的存在。本研究通过横断面调查,旨在确定在伊斯坦布尔市,风疹病毒传播是否能在一组随机选取的孕妇和非孕妇中诱导出具有保护水平的可检测免疫球蛋白G(IgG)抗体。
160名年龄在20至41岁(平均24岁)的女性被分为以下几组:1. 48名已婚女性。其中有41名孕妇(33名顺产,8名流产)。2. 112名单身女性。样本采集时间为2000年10月至2001年3月以及2001年11月至2002年5月。对所有受试女性检测风疹特异性IgG抗体(采用酶联免疫吸附测定法)。
IgG水平的定量分析显示出显著差异,范围在24至143国际单位/毫升之间(平均94)。160名女性中有145名(91%)风疹IgG水平高于50国际单位/毫升,范围为54至143国际单位/毫升(平均92),而15名(9%)的水平在24至46国际单位/毫升之间(平均38)。风疹IgG亲和力检测显示,116名(73%)女性具有高IgG亲和力,22名(14%)具有中等亲和力,20名(13%)显示低亲和力。两名IgM呈阳性的女性,其IgG亲和力要么高要么中等。
所有受试女性风疹特异性IgG抗体血清学检测均为阳性,提示社区内存在自然病毒传播。尽管大多数人似乎拥有此类抗体的保护水平,但为预防未来再次感染,筛查保护性免疫力似乎始终是必要的。